Pathogenetic Mechanisms in Gram-Positive Shock: Studies on the Ability of Streptococcus pyogenes to Induce Nitric Oxide In Vitro

  • P. Mills
  • T. Evans
  • J. Cohen
Conference paper

Abstract

Sepsis and its sequelae are a cause of significant morbidity and mortality worldwide. Septic shock is a clinical syndrome that has become increasingly important in the past 40 years (Glauser et al. 1991) and has been increasing in incidence since the early part of this century (Parrillo et al. 1990; Billiau and Vandekerckhove 1991). Much work has been conducted in elucidating the pathogenic mechanisms responsible for the deleterious effects seen in this condition.

Keywords

Pneumonia Cysteine Nitrite Glutamine Dexamethasone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bayston K, Tomlinson M, Cohen J (1992) In-vitro stimulation of TNFα from human whole blood by cell free supernatants of gram-positive bacteria. Cytokine 4: 397–402PubMedCrossRefGoogle Scholar
  2. Billiau A, Vandekerckhove F (1991) Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur J Clin Invest 21: 559–573PubMedCrossRefGoogle Scholar
  3. Bogdan C, Vodovotz Y, Paik J, Xie Q, Nathan C (1993) Traces of bacterial lipopolysaccharide suppress IFNγ induced nitric oxide synthase gene expression in primary mouse macrophages. J Immunol 151: 301–309PubMedGoogle Scholar
  4. Braun MA, Gerlach D, Hartwig UF, Ozegowski JH, Romagne F, Carrel S, Kohler W, Fleischer B (1993) Stimulation of human T cells by streptococcal “superantigen” erythrogenic toxins (scarlet fever toxins). J Immunol 150: 2457–2466PubMedGoogle Scholar
  5. Cobb JP, Cunnion RE, Danner RL (1993) Nitric oxide as a target for therapy in septic shock. Crit Care Med 21: 1261–1263PubMedCrossRefGoogle Scholar
  6. Cohen J, McConnell JS (1984) Observations on the measurement and evaluation of endotoxaemia by a quantitive Limulus lysate microassay. J Infect Dis 150: 916–924PubMedCrossRefGoogle Scholar
  7. Cunha FQ, Moss DW, Leal LMCC, Moneada S, Liew FY (1993) Induction of macrophage parasiticidal activity by Staphylococcus aureus and exotoxins through the nitric oxide synthesis pathway. Immunology 78: 563–567PubMedGoogle Scholar
  8. Ding AH, Nathan CF, Stuehr DJ (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J Immunol 141: 2407–2412PubMedGoogle Scholar
  9. Evans T, Carpenter A, Silva A, Cohen J (1992) Differential effects of monoclonal antibodies to tumour necrosis factor alpha and gamma interferon on induction of hepatic nitric oxide synthase in experimental gram negative sepsis. Infect Immun 60: 4133–4139PubMedGoogle Scholar
  10. Evans T, Carpenter A, Kinderman H, Cohen J (1993) Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 41: 77–81PubMedGoogle Scholar
  11. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387–389PubMedCrossRefGoogle Scholar
  12. Furchgott RF, Zawadski JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373–376PubMedCrossRefGoogle Scholar
  13. Gascoigne NR (1993) Interaction of the T cell receptor with bacterial superantigens. Immunology 5: 13–21Google Scholar
  14. Glauser MP, Zanetti G, Baumgartner J-D, Cohen J (1991) Septic shock — pathogenesis. Lancet 338: 732–736PubMedCrossRefGoogle Scholar
  15. Green SJ, Chen TY, Crawford RM, NacyCA, Morrison DC, MeltzerMS (1992) Cytotoxic activity and production of toxic nitrogen oxides by macrophages treated with IFNγ and monoclonal antibodies against the 73-kDa lipopolysaccharide receptor. J Immunol 149: 2069–2075Google Scholar
  16. Hackett SP, Stevens DL (1992) Streptococcal toxic shock syndrome: synthesis of tumour necrosis factor and interleukin-i by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. J Infect Dis 165: 879–85PubMedCrossRefGoogle Scholar
  17. Houston CW, Ferretti JJ (1981) Enzyme linked immunosorbent assay for detection of type A streptococcal exotoxin: kinetics and regulation during growth of Streptococcus pyogenes. Infect Immun 33: 862–869PubMedGoogle Scholar
  18. Ignarro LJ (1989) Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 65: 1–21PubMedGoogle Scholar
  19. Ispahani P, Pearson NJ, Greenwood D (1987) An analysis of community and hospital acquired bacteraemia in a large teaching hospital in the United Kingdom. Q J Med 63: 427–440PubMedGoogle Scholar
  20. Kanno K, Hirata Y, Imai T, Marumo F (1993) Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension 22: 34–39PubMedGoogle Scholar
  21. Kapur V, Majesky MW, Li LL, Black RA, Musser JM (1993) Cleavage of interleukin 1β 1L-1β precursor to produce active IL-1β by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci USA 90: 7676–7680PubMedCrossRefGoogle Scholar
  22. Kilbourn RG, Griffith OW (1992) Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 84: 827–831PubMedCrossRefGoogle Scholar
  23. Krausz T, Cohen J (1992) Shock. In: McGee JO, Isaacson PG, Wright NA (eds) Oxford textbook of pathology. Oxford University Press, Oxford, 540–551Google Scholar
  24. Labrecque N, Thibodeau J, Sekaly RP (1993) Interactions between staphylococcal superantigens and MHC class II molecules. Immunology 5: 23–32Google Scholar
  25. Leonard BAB, Schlievert PM (1992) Immune cell lethality induced by streptococcal pyrogenic exotoxin A and endotoxin. Infect Immun 60: 3747–3755PubMedGoogle Scholar
  26. LonchamptMO, Auguet M, Delaflotte S, Goulin-Schultz J, Chabrier PE, Braquet P (1992) Lipoteichoic acid: a new inducer of nitric oxide synthase. J Cardiovasc Pharmacol 20: 5145–5147Google Scholar
  27. Lorente JA, Landin L, De Pablo R, Renes E, Liste D (1993) L-arginine pathway in the sepsis syndrome. Crit Care Med 21: 1287–1295PubMedCrossRefGoogle Scholar
  28. Marks JD, Marks CB, Luce JM, Montgomery AB, Turner J, Metz CA, Murray JF (1990) Plasma tumour necrosis factor in patients with septic shock. Am Rev Respir Dis 141: 94–97PubMedGoogle Scholar
  29. Moncada S (1992) The L-arginine: nitric oxide pathway. Acta Physiol Scand 145: 201–227PubMedCrossRefGoogle Scholar
  30. Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051–3064Google Scholar
  31. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, Peitzman AB (1991) Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214: 621–626PubMedCrossRefGoogle Scholar
  32. Palmer RM (1993) The discovery of nitric oxide in the vessel wall. Arch Surg 128: 396–401PubMedCrossRefGoogle Scholar
  33. ParrilloJE, Parker MM, Natanson C, Suffredini AF, DannerRL, Cunnion RE, Ognibene FP (1990) Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann Intern Med 113: 227–242Google Scholar
  34. Parsonnet J, Gillis ZA (1988) Production of tumour necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-i. J Infect Dis 158: 1026–1033PubMedCrossRefGoogle Scholar
  35. Shaunak S, Wendon J, Monteil M, Gordon AM (1988) Septic scarlet fever due to Streptococcus pyogenes cellulitis. Q J Med 69: 921–925PubMedGoogle Scholar
  36. Silva AT, Bayston KF, Cohen J (1990) Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor in experimental gram negative shock. J Infect Dis 162: 421–427PubMedCrossRefGoogle Scholar
  37. Stevens DL (1992) Invasive group A streptococcus infections. Clin Infect Dis 14: 2–13PubMedCrossRefGoogle Scholar
  38. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E (1989) Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321: 1–7PubMedCrossRefGoogle Scholar
  39. Wayte J, Silva AT, Krausz T, Cohen J (1993) Observations on the role of tumor necrosis factor a in a murine model of shock due to Streptococcus pyogenes. Crit Care Med 21: 1207–1212PubMedCrossRefGoogle Scholar
  40. Working Group on Severe Streptococcal Infections (1993) Defining the group A streptococcal toxic shock syndrome. JAMA 269: 390–391Google Scholar
  41. Zembowicz A, Vane JR (1992) Induction of nitric oxide synthase activity by toxic shock syndrome toxin 1 in a macrophage-monocyte cell line. Proc Natl Acad Sci U S A 89: 2051–2055PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • P. Mills
  • T. Evans
  • J. Cohen

There are no affiliations available

Personalised recommendations